Description
Developed to bridge the gap between in vitro testing and clinical efficacy, this kit enables the robust co-culture of lung cancer organoids with primary immune cells (e.g., TILs, NK cells). Specifically optimized to sustain the viability of both components within a single system, it offers a reliable platform for assessing the anti-tumor activity of unedited cellular immunotherapies and exploring the tumor-immune microenvironment.